HortaPharm B.V. is a cannabis research business headquartered in the Netherlands.[1]
| Industry | Horticulture |
|---|---|
| Founder | David Paul Watson |
| Headquarters | , |
| Products | Cannabis seeds and clones |
History
editThe business was founded by American David Watson also known as Sam Selezny or 'SkunkMan Sam' in the early 1990s, with seeds he created for his company, Sacred Seeds in California. David, Pate, and Robert C. Clarke were employed by the company.[2] From September 1994 until September 1997 HortaPharm had a permit from the Dutch Ministry of Health for scientific research of cannabis; this permit was rescinded due to compliance issues. In 1998, HortaPharm B.V. began work with GW Pharmaceuticals to develop cannabis strains for the manufacture of pharmaceuticals.[3]
Research
editHortaPharm B.V. has used selective breeding and production for research of cannabis strains, with a focus on the isolation of tetrahydrocannabinol or cannabidiol.[4] GW Pharmaceuticals has exclusive rights to all genetics produced by HortaPharm B.V with the goal of producing one-off sterile female plants to control supply.[5] Lab Supervisor, David Pate, gave a lecture at the National Academy of Sciences in Washington, D. C. on February 24, 1998, as part of the Institute of Medicine study to evaluate the therapeutic value of marijuana and its chemical components.[6]
Patents
editIn March of 2000, HortaPharm B.V. filed a patent for a vaporizer with enhanced isolation chambers for ascending-steam extraction, with the invention attributed to David Pate. [7] GW Pharmecuticals have filed multiple patents based on their work with HortaPham B.V.
References
edit- ^ "Hortapharm B.V." Archived from the original on 2013-10-05. Retrieved 2012-07-19.
- ^ Breen, Bill (2004-02-01). "Dr. Dope's Connection". Fast Company. Retrieved 2019-08-07.
- ^ "Details released of collaboration between GW Pharmaceuticals and Hortapharm medicinal cannabis". Archived from the original on 2012-07-30. Retrieved 2012-07-19.
- ^ The Inheritance of Chemical Phenotype in Cannabis sativa L. (HortaPharm B.V., 1075 VS, Amsterdam, the Netherlands)
- ^ "HortaPharm Interview". UK Journal. 1998.
- ^ "Development of Cannabis-based therapeutics". International Hemp Association.
- ^ "US patent for enhanced isolation chambers for ascending-stream extractive vaporizer". Justia Patents.
 | This Cannabis-related article is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |